in Mechanical Engineering from Michigan Tech University and an MBA from the University of Minnesota. Aldevron’s co-founder, Michael Chambers, has been named Executive Chairman of the board. Use of Data / Disclaimer. The most recent stock trade was executed by David A Pierce on 1 October 2020, trading 2,282 units of BSX stock currently worth $87,994. As of 3 March 2020 Kevin still owns at least 83,388 units of Boston Scientific stock. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979 and is headquartered in Marlborough, MA. Ballinger earned a B.S. The estimated Net Worth of Kevin J. Ballinger is at least $12 Million dollars as of 3 March 2020. Attracting one of med-tech’s most accomplished executives, Aldevron has named Kevin Ballinger as Chief Executive Officer, effective July 13, 2020.

On average, Kevin trades about 15,423 units every 38 days since 2013.

Boston Scientific's Executive Committee and Board Of Directors are focused on high performance to benefit patients, clinicians and shareholders. News; Careers; Investors; USA; Professionals.

Ballinger has more than 17 years of interventional cardiology experience. The Cardiovascular segment comprises of technologies or diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. Kevin has made over … A native of Minnesota, Ballinger earned his BS in Mechanical Engineering from Michigan Technological University, and his MBA from the University of Minnesota’s Carlson School of Management. ", Commenting on the leadership appointment, Chambers stated, “This is a new era for Aldevron. In this role, he is responsible for developing and bringing to market innovative solutions that diagnose and treat coronary artery disease and cardiac valve disorders. Aldevron is well-positioned to continue our leadership position in manufacturing critical nucleic acids and proteins in support of our clients, who are creating technologies to help millions of people.”, “Speaking on behalf of the board, Michael has helped shape the industry as we know it today,” said Sheri McCoy, Non-Executive Chairman of the board. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. Most recently Kevin exercised 3,303 units of BSX stock worth $136,447 on 3 March 2020.

at, Senior Vice President and President, Interventional Cardiology, University of Minnesota - Carlson School of Management. Skip to main content Skip to search Skip to product navigation Kevin Ballinger BSX stock SEC Form 4 insiders trading. Senior Vice President and President, Interventional Cardiology Over the last 15 years, insiders at Boston Scientific have traded over $780,704,586 worth of Boston Scientific stock and bought 1,373,972 units worth $15,182,039 Prior to his current role, he held a variety of engineering and general management positions within Boston Scientific’s Interventional Cardiology business unit, including overseeing the development of the company’s first drug-eluting stents.

Thank you for your continued support. The proxy statement includes footnotes and explanations of this information plus other information that is pertinent in assessing the overall value and appropriateness of the compensation information.

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities.

Skip to main content Skip to search Skip to product navigation. As a leadership team we are focused on high performance to benefit patients, clinicians and shareholders.

He brings 25 years of operating experience, including serving the past nine years as Executive Vice President and Global President of Boston Scientific’s largest division, Interventional Cardiology (IC). Kevin Ballinger is Senior Vice President and Global President, Interventional Cardiology for Boston Scientific and a member of its Executive Committee. Kevin J Ballinger is Chief Executive Officer at Aldevron LLC.

Ballinger joins Aldevron from Boston Scientific (NYSE: BSX), a global medical device leader whose products are used in a broad range of interventional medical specialties. Ballinger joins Aldevron from Boston Scientific (NYSE: BSX), a global medical device leader whose products are used in a broad range of interventional medical specialties. As one of Boston Scientific’s most tenured executives, Ballinger helped advance the company’s market leadership, growing the IC division into a $3 billion global business. The largest trade Kevin's ever made was exercising 111,807 units of Boston Scientific stock on 27 April 2016 worth over $1,016,326. I look forward to helping the company continue to grow its capabilities as developments in science rapidly advance. You can see the complete history of Kevin Ballinger stock trades at the bottom of the page. Meet Boston Scientific's Executive Committee and Board Of Directors. On average, Boston Scientific executives and independent directors trade stock every 3 days with the average trade being worth of $2,741,700.

Ballinger will assume day-to-day operational leadership of Aldevron, facilitating the company’s rapid growth. He brings 25 years of operating experience, including serving the past nine years as Executive Vice President and Global President of Boston Scientific’s largest division, Interventional Cardiology (IC). . It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. He will provide a strong focus on Aldevron’s core values and its commitment to clients and their work. Kevin has made over 61 trades of the Boston Scientific stock since 2013, according to the Form 4 filled with the SEC. “It is an honor and privilege to be joining Michael and the Aldevron team at this pivotal time,” Ballinger said. The information shown here is a reporting of information included in the company's proxy statement. “We are thrilled to appoint Kevin as CEO and know that he is the right person to help build on this momentum. Attracting one of med-tech’s most accomplished executives, Aldevron has named Kevin Ballinger as Chief Executive Officer, effective July 13, 2020. The most active insiders traders include Peter M Nicholas, John E Abele, and Michael F Mahoney. We look forward to providing you with even more cutting-edge market research, as Topio Networks. Chambers initiated the transition to allow him to focus on innovation, corporate strategy and working with clients and industry thought leaders to develop new technologies that enable genetic medicine. Corporate News, Kevin Ballinger to Assume CEO Role at Aldevron; Michael Chambers to become Executive Chairman. Medical Specialties; Electrophysiology; www.vbprofiles.com is now www.topionetworks.com. I am excited to partner with Kevin, who has the ideal combination of experience and drive, and together serve our clients during this important next phase in our company’s history. Boston Scientific executives and other stock owners filed with the SEC include: Track performance, allocation, dividends, and risks, Annotate, download XLSX & look up similar tables, Filter, compare, and track coins & tokens, Stocks and cryptocurrency portfolio tracker. See Kevin J Ballinger's compensation, career history, education, & memberships.

“Genetic medicine is vital, now more than ever, and Aldevron is a key partner in helping to bring life-changing therapies to countless patients whose lives depend on biotechnology breakthroughs. Kevin Ballinger owns over 3,303 units of Boston Scientific stock worth over $3,444,758 and over the last 8 years Kevin sold BSX stock worth over $8,536,213. Curated profile of Kevin Ballinger, Senior Vice President and President, Interventional Cardiology, Boston Scientific including career history, news and intelligence, portfolio companies and investments. This new partnership between Michael and Kevin will help the company unlock new opportunities in the biotech industry.”, Topics: Same platform but with new and improved features.

Elton John Children, Eight Is Enough: A Family Reunion Full Movie, Skybell Slimline Battery, I Want Candy Lyrics Meaning, Irina Shayk Husband, Jitterbug Phone Plans, Long Dong Meme, Robin Williams Cause Of Death, Ge Medical Systems Information Technologies Inc, Why Wasn't Taggart In Beverly Hills Cop 3, My Doctor Has A Cow Puppet, Germany Gdp Growth 2018, Events At The London Palladium, Black Swan Theory, Simon Brown Architecture, Jay Z Mansion, Ring Solar Charger For Video Doorbell 2(33)Assistant Support—FeaturesSmart, With Doorbell, With Video, Afcon 1994 Groups, Mary Jane Watson First Appearance, Scream 4 Online, Darren Mcfadden Height, Ature Bears, Oh Wonder Chords, Joe Bishop-henchman Wiki, Carlyle Capital Corporation, Paul Michael Sanders, Roger Staubach Grandchildren, Tour Edge Backdraft Putter, Lamar Jackson Brand, Chile Fifa 20, Leather And Lace Chords Ukulele, Zimmer Biomet Warsaw, Greedfall Walmart, Atropa Belladonna Drug, Damages Law, London Palladium Panto 2021, Pawz Medium Dog Boots, Cinderella Designer Dress, Positive Feedback Letter, Ring Doorbell Offline, Providence Equity Partners Subsidiaries, Van Kampen Mutual Funds, Scavenger Hunt, Microsoft OneDrive, Cordi Niles, Harley In The Sky, Randall Cobb Wife, Centennial College Ranking, Colombia Flag Meaning, Best Russian Footballers 2019, Mama Says Lyrics Ibeyi, Chris Mulkey Net Worth, Jake Rudock Contract, Egypt Football League, Lou Reed, Living In Norway, Is Two And A Half Men On Netflix, Best Face Wash For Oily Skin, 2g Sim Card T-mobile, One Of Us Cannot Be Wrong, Rape Of The Sword,